CLINICAL TRIALS PROFILE FOR EPLIVANSERIN
✉ Email this page to a colleague
Clinical Trials for Eplivanserin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00253903 ↗ | Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year | Completed | Sanofi | Phase 3 | The purpose of the study is to assess efficacy and safety of eplivanserin in the population of patients complaining of sleep maintenance insomnia. The patients suffering from that condition frequently wake up during the night, their sleep is nonrestorative and they suffer from a significant distress or impairment in their daily activities consecutive to insomnia. |
NCT00253968 ↗ | Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia | Completed | Sanofi | Phase 3 | The purpose of the study is to assess efficacy and safety of eplivanserin in the population of patients complaining of sleep maintenance insomnia. The patients suffering from that condition frequently wake up during the night, their sleep is nonrestorative and they suffer from a significant distress or impairment in their daily activities consecutive to insomnia. |
NCT00308503 ↗ | Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia | Completed | Sanofi | Phase 3 | The aim of the study is to confirm the efficacy of eplivanserin 5mg/day on sleep maintenance of patients with primary insomnia using night polysomnography recordings over a 6-week treatment period corresponding to a stabilization of improvement of sleep. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Eplivanserin
Condition Name
Clinical Trial Locations for Eplivanserin
Trials by Country
Clinical Trial Progress for Eplivanserin
Clinical Trial Phase
Clinical Trial Sponsors for Eplivanserin
Sponsor Name